About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

Novo Nordisk (NVO.N) has filed for regulatory approval of an oral formulation of Wegovy for weight management.

2026-08-27

Novo Nordisk (NVO.N) has filed for regulatory approval of an oral formulation of Wegovy for weight management.

Other News
2026-08-26

On August 26, flash floods struck Rasuwa district in northern Nepal’s Bagmati province, sweeping villages, markets and infrastructure. The Nepal Tourism Board said at least 16 people have died and 384 tourists are missing, including 93 Nepalis and th

On August 26, flash floods struck Rasuwa district in northern Nepal’s Bagmati province, sweeping villages, markets and infrastructure. The Nepal Tourism Board said at least 16 people have died and 384 tourists are missing, including 93 Nepalis and the remainder foreign nationals. Scientists’ preliminary assessment is that an icefall blocked the Lende River, forming a temporary dam that later breached; investigators say the cause remains under review. Damage to roads, bridges, communications and power have hampered rescue operations and water levels in the mountains remain high, delaying a full accounting of casualties and property losses. A local resident said the event near the Nepal–China border may be the largest in decades and could be linked to glacier melt.
2026-08-27

The Governor of the Bank of Korea said: "The Korean won still has room for further appreciation, and we will work in that direction."

The Governor of the Bank of Korea said: "The Korean won still has room for further appreciation, and we will work in that direction."
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2026 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.